National Cancer Institute (NCI), NIH
Dr. Mariam Eljanne serves as a Program Director in the Division of Cancer Biology at the National Cancer Institute. In this role, she oversees the scientific progress of grants under different funding mechanisms.
Dr. Eljanne earned a MS. in Microbial Genetics from the University of North Carolina at Charlotte and a Ph.D. in Human Genetics from the University of Pittsburgh. She has broad expertise in basic sciences, translational research, and clinical research. After earning her Master’s degree, Dr. Eljanne managed the Molecular Diagnostics laboratory for infectious diseases at the University of Pittsburgh Medical Center. She then joined the Department of Human Genetics at the University of Pittsburgh where she worked on gene therapy, stem cell research, and genomic imprinting. Dr. Eljanne studied the methylation pattern of DNA in the mouse. After earning her Ph.D. she joined Cytyc Corporation where she worked on breast and cervical cancer diagnostic assay development. In 2004 she moved to Beth Israel Deaconess Medical Center (BIDMC) as a Senior Research Associate where she worked on prostate cancer diagnostic/prognostic assay development and prostate clinical research. With this clinical research experience from BIDMC, Dr. Eljanne joined the Johns Hopkins School of Medicine Lupus Center as a Research Program Manager where she managed several industry-sponsored lupus clinical trials. In 2009 Dr. Eljanne joined the National Institute of Allergy and Infectious Diseases to manage the Vaccine Treatment and Evaluation Units clinical trial contract. Dr. Eljanne’s interest lies in basic and translational research.